Clinical Trial Update: Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing dociparstat sodium (CX-01) in combination with standard induction therapy for newly diagnosed acute myeloid leukemia has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dociparstat Sodium (CX-01) (dociparstat sodium)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-10-29